Walmart Announces New, Low-Price Insulin For Diabetics.
Walmart Announces New, Low-Price Insulin For Diabetics.
Vials of the private-label version of
ReliOn NovoLog will be sold by Walmart to
uninsured patients with a prescription for $73.
Vials of the private-label version of
ReliOn NovoLog will be sold by Walmart to
uninsured patients with a prescription for $73.
Uninsured patients can also get packages
of pre-filled insulin pens for $86.
This price point, we hope, will improve and hopefully revolutionize the accessibility and affordability
of insulin, Dr. Cheryl Pegus, Walmart’s Executive Vice
President of Health and Wellness, via CNBC.
We know that many people with diabetes struggle to manage this chronic condition because of its financial burden, Dr. Cheryl Pegus, Walmart’s Executive Vice
President of Health and Wellness, via CNBC.
Walmart already offers a low-cost insulin for $25 a vial
through its ReliOn line of products.
But the new low-cost insulin is considered more
effective at regulating blood sugar. .
According to data from 2016, yearly insulin
costs for diabetics are about $5,700 on average